DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Sumitomo Chemical India Limited — Integrated Filing- Financial

NSE 1 hr ago·26 Oct 2026, 10:27 am

Sumitomo Chemical India

Sumitomo Chemical India Limited has submitted its financial filings for the quarter and half-year ended September 30, 2026. This integrated filing provides a comprehensive overview of the company's performance during this period.

For investors, this update is a key milestone for tracking the company's financial health and operational progress. It allows stakeholders to assess the company's trajectory and make informed decisions based on the latest available data.

Investors should closely review the financial results for any significant trends or changes in key performance indicators. Keeping an eye on future guidance and market conditions will be essential to understanding the company's next steps.